Senior Scientist, Cell and Molecular Biology, Gene Editing
Editas Medicine
About this role
Editas Medicine is seeking a Senior Scientist in Molecular and Cell Biology to leverage expertise in gene editing, develop disease models, and advance CRISPR-based therapeutics as part of their drug development pipeline.
Skills
About Editas Medicine
editasmedicine.comEditas Medicine is a leading biotechnology company focused on developing CRISPR-based medicines to treat people with serious diseases. It pioneers genome-editing therapies, translating CRISPR research into clinical programs aimed at delivering transformative treatments. The company concentrates on building a pipeline of investigational medicines and collaborating across the biotech ecosystem to advance gene editing from the lab to the clinic. By leveraging precision genome editing, Editas Medicine seeks to expand treatment options for patients with previously intractable conditions.
Recent company news
Editas Medicine (NASDAQ:EDIT) CEO Gilmore Neil O'neill Sells 5,394 Shares
1 day ago
EDIT Financials: Income Statement, Balance Sheet & Cash Flow
3 days ago
Editas Medicine to Participate in Upcoming Investor Conferences
1 week ago
Editas Medicine: Three Strikes And It's Out, Or Third Time’s The Charm?
Oct 14, 2025
Individual investors who hold 55% of Editas Medicine, Inc. (NASDAQ:EDIT) gained 14%, institutions profited as well
1 month ago
About Editas Medicine
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Editas Medicine.
Salary
$150k – $165k
per year
More jobs at Editas Medicine
Similar Jobs
Researcher for Center for Advanced Genome Engineering
St. Jude
Postdoc - Therapeutic Epigenetic Editing in vivo
EMBL
Co-op: Off-Target Analysis of Gene Editing
Prime Medicine
Scientist, Non-Viral Gene Editing Platforms
0468 BMS Polska Sp. z o.o.
Senior Research Associate, Cell & Molecular Biology
Flagship Pioneering, Inc.
Research Intern, Translational Biology
ElevateBio